This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
bacteria:t3e:xopv [2021/01/07 05:14] s_tsuge [Biological function] |
bacteria:t3e:xopv [2021/01/07 06:08] (current) s_tsuge [Biological function] |
||
---|---|---|---|
Line 3: | Line 3: | ||
Author: Coline Sciallano\\ | Author: Coline Sciallano\\ | ||
Internal reviewer: [[https:// | Internal reviewer: [[https:// | ||
- | Expert reviewer: | + | Expert reviewer: |
Class: XopV\\ | Class: XopV\\ | ||
Line 18: | Line 18: | ||
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
- | TT3S-dependent translocation of XopV has been shown by a calmodulin-dependent adenylate cyclase reporter assay (Furutani //et al//., 2009). | + | TT3S-dependent translocation of XopV has been shown by a calmodulin-dependent adenylate cyclase reporter assay (Furutani //et al//., 2009). |
=== Regulation === | === Regulation === | ||
- | //xopV// was shown to contain the PIP-box motif in their promoter region, and the expression was found to be regulated by HrpX using a b -glucuronidase (GUS) reporter assay in CKGE_TMP_i | + | //xopV// was shown to contain the PIP-box motif in their promoter region, and the expression was found to be regulated by HrpX using a β -glucuronidase (GUS) reporter assay in //hrp//-inducing medium (Tsuge //et al.//, 2005). |
=== Phenotypes === | === Phenotypes === | ||
- | < | + | < |
- | < | + | < |
- | < | + | < |
=== Localization === | === Localization === | ||
Line 55: | Line 57: | ||
Furutani A, Takaoka M, Sanada H, Noguchi Y, Oku T, Tsuno K, Tsuge S (2009). Identification of novel type III secretion effectors in // | Furutani A, Takaoka M, Sanada H, Noguchi Y, Oku T, Tsuno K, Tsuge S (2009). Identification of novel type III secretion effectors in // | ||
- | |||
- | Liu Y, Long J, Shen D, Song C (2016). // | ||
Long J, Song C, Yan F, Zhou J, Zhou H, Yang B (2018). Non-TAL effectors from // | Long J, Song C, Yan F, Zhou J, Zhou H, Yang B (2018). Non-TAL effectors from // | ||
+ | |||
+ | Popov G, Fraiture M, Brunner B, Sessa G (2016). Multiple // | ||
Song C, Yang B (2010). Mutagenesis of 18 type III effectors reveals virulence function of XopZ< | Song C, Yang B (2010). Mutagenesis of 18 type III effectors reveals virulence function of XopZ< | ||
+ | |||
+ | <font 14px/ | ||